Deciphering mitochondrial dysfunction in keratoconus: Insights into ACSL4 from machine learning-based bulk and single-cell transcriptome analyses and experimental validation.

解读圆锥角膜中的线粒体功能障碍:基于机器学习的批量和单细胞转录组分析及实验验证对 ACSL4 的见解

阅读:6
作者:Cai Yuchen, Zhou Tianyi, Cai Xueyao, Shi Wenjun, Sun Hao, Fu Yao
Keratoconus (KC) is a prevalent ectatic corneal disease and the leading cause of corneal transplantation globally. Despite evidence of mitochondrial abnormalities in KC, the underlying mechanisms remain unclear. Our aim was to investigate the role of mitochondrial dysfunction in this pathological condition. Based on transcriptomics datasets of KC, mitochondria-related differentially expressed genes (mDEGs) were identified and analyzed for potential functional pathways, protein-protein interaction (PPI), and gene regulatory networks. Hub genes were further screened and validated by multiple machine learning (ML) algorithms, followed by a comprehensive visualization of single-cell atlas and immune landscape. Additionally, bioinformatic results were validated through quantitative PCR, Western blot, and transcriptomics analysis in an in vitro KC model based on matrix stiffness using human stromal keratocytes. In total, 104 mDEGs were identified, enriched in pathways related to oxidative stress, apoptotic mitochondrial changes, ferroptosis, and inflammatory responses. Nine characteristic genes (CYP24A1, ACSL4, ACADL, HELZ2, AMT, DEPTOR, TUBA1A, TYMS, and ACSL5) were selected and validated using multiple ML models. Single cell sequencing data highlighted ACSL4 as the most promising biomarker, primarily expressed in corneal stromal cells (CSCs). Immune infiltration analysis revealed that ACSL4 was positively associated with monocytes and negatively correlated with eosinophils in KC. In cellular experiments, ACSL4 expression was significantly upregulated in response to decreased substrate stiffness, suggesting its critical role in KC development. These findings suggest a mitochondrial-related molecular mechanism implicated in KC pathogenesis. The identified pivotal biomarker ACSL4 provides a novel framework for future mechanistic and therapeutic studies of KC.

特别声明

1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。

2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。

3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。

4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。